Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
2018
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells
2003
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
2003
Involvement of the serine/threonine p70S6 kinase in TGF-β1-induced ADAM12 expression in cultured human hepatic stellate cells
2005
Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells
2006
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Biological Effects of C-type Natriuretic Peptide in Human Myofibroblastic Hepatic Stellate Cells
1999
PDGF and signal transduction in hepatic stellate cells
2002
Liver fibrosis
2005 Standout
Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA mircoarray
2004
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Mechanisms of liver fibrosis
2005
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
2009
NOX in liver fibrosis
2007
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
2011
Liver fibrosis – from bench to bedside
2003 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
2003
PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
2009
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Curcumin improves sclerosing cholangitis in Mdr2 −/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation
2010
Adipogenic Transcriptional Regulation of Hepatic Stellate Cells
2004
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
2011
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
2014
Non-alcoholic fatty liver disease: The mist gradually clears
2008
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Pharmacological agents for NASH
2013
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
2008
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Fibrogenic effect of oxidative stress on rat hepatic stellate cells
1998
Regulation of PDGF and its receptors in fibrotic diseases
2004
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Gut–Liver Axis in Alcoholic Liver Disease
2014
Non-alcoholic fatty liver disease
2021 Standout
Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.
1996
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Hepatitis C virus infection
2017
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
2009
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
2004
Iron-induced oxidant stress in alcoholic liver fibrogenesis
2003
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Inhibition of the Na+/H+ exchanger reduces rat hepatic stellate cell activity and liver fibrosis: An in vitro and in vivo study
2001
Smooth Muscle α Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing
2013
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
2004
Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis
2006
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
Adipogenic Phenotype of Hepatic Stellate Cells
2005
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
2008
Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
2010
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Tumor Necrosis Factor α-dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis
2003
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells
1999
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
2003
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has A Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling Pathway
2010
Hepatocellular Carcinoma
2011 Standout
Antifibrotic activities of pirfenidone in animal models
2011
Adipokines in liver diseases #
2009
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Peroxisome Proliferator-activated Receptor γ Suppresses Proximal α1(I) Collagen Promoter via Inhibition of p300-facilitated NF-I Binding to DNA in Hepatic Stellate Cells
2005
The Myofibroblast
2007 Standout
The potential role of genes in nonalcoholic fatty liver disease
2004
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells
1994
Evaluation of Liver Fibrosis: A Concise Review
2004
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Liver nbsp fibrosis signals leading to the amplification of the fibrogenic hepatic stellate cell
2003
Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: Potential role in liver injury*1
1995
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
2003
Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: Potential role in liver injury
1995
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
2018
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation
2005
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation
2006
Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus
2016
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
2015
NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells†
2005
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
An adipocentric view of liver fibrosis and cirrhosis.
2004
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Gut Microbiota and Host Reaction in Liver Diseases
2015
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of L. Trozzi being referenced
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
2017
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat
2003
Glucagon-Like Peptide-1 and Its Receptor Agonist Exendin-4 Modulate Cholangiocyte Adaptive Response to Cholestasis
2007
Quantitative analysis of proliferating sinusoidal cells in dimethylnitrosamine-induced cirrhosis
1992
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
2008
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
2014
Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis
2003
Intracellular pH regulation and Na + /H + exchange activity in human hepatic stellate cells: effect of platelet-derived growth factor, insulin-like growth factor 1 and insulin
2001
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
2002
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
2002
Endogenous Opioids Modulate the Growth of the Biliary Tree in the Course of Cholestasis
2006
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2
2004
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: Possible implications for sclerosing cholangitis
2012
Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice
2013
Leptin Enhances Cholangiocarcinoma Cell Growth
2008